References
- Warrel R. P., Frankel S. R., Miller W. H., et al. Differentiation therapy of acute promyelocytic leukemia with tretinoin (alltrans retinoic acid). N Engl J Med 1991; 324: 1385–93
- Huang M. E., Ye Y. C., Chen S. R., et al. Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia. Blood 1988; 72: 567–72
- Castaigne S., Chomienne C., Daniel M. T., et al. All-trans retinoic acid as a differentiation therapy for acute promyelocytic leukemia. Blood 1990; 76: 1704–9
- Ohno R., Naoe T., Hirano M., et al. Treatment of myelodys-plastic syndromes with all-trans retinoic acid. Blood 1993; 8J: 1152–4
- Ohno R., Yoshida H., Fukatani H., et al. Multiinstitutional study of all-trans retinoic acid as a differentiation therapy of refractory acute promyelocytic leukemia. Leukemia 1993; 7: 1722–7
- Frankel S. R., Eardly A., Lauwers G., Weiss M., Warrell RP, Jr. The ‘Retinoic acid syndrome’ in acute promyelocytic leukemia. Ann Intern Med 1992; 117: 292–6
- Fenaux P., Le Deley M. C., Castaigne S., et al. Effect of all-trans retinoic acid in newly diagnosed acute promyelocytic leukemia. Results of a multicenter randomized trial. Blood 1993; 82: 3241–9
- Doppman J. L., Girton M. E. Bile duct scarring following ethanol embolization of the hepatic artery: An experimental study in monkeys. Radiology 1984; 152: 621–6
- Dikengil A., Siskind B. N., Morse S. S. Sclerosing cholangitis from intra-arterial floxuridine. J Clin Gastroenterol 1986; 8: 690–3
- Edwards C. M., Otal M. P., Stacpoole P. W. Lipoprotein X fails to inhibit hydroxymethylglutaryl coenzyme A reductase in HepG 2 cells. Metabolism 1993; 42: 807–13
- Miyahara K., Kasahara N., Kondo Y., Imai Y., Matuzaki F. Changes in plasma lipids and abnormal lipoproteins in a patient with drug-induced cholestatic hepatitis. Jpn J Med 1991; 30: 354–9
- Perales J., Angel-Lasuncion M., Cano A., Martin-Scapa M. A., Maties M., Herrera E. Changes in the lipid profile in chronic hepatopathies. Med Clin Bare 1994; 102: 364–8